Evidence map›Paper›PMID 39434445›Full record

ArticleDiabetes, obesity & metabolism2025

The associations between functional vitamin K status and all-cause mortality, cardiovascular disease and end-stage kidney disease in persons with type 1 diabetes.

Camilla Friis Bryde Nielsen, Sanne Møller Thysen, Freja Bach Kampmann, Tine Willum Hansen, Niklas Rye Jørgensen, Nete Tofte, Signe Abitz Winther, Simone Theilade, Peter Rossing, Marie Frimodt-Møller and 1 more

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Camilla Friis Bryde NielsenCenter for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.ORCID 0000-0002-8814-2104
Sanne Møller ThysenCenter for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Freja Bach KampmannCenter for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Tine Willum HansenSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID 0000-0003-2274-0352
Niklas Rye JørgensenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nete TofteSteno Diabetes Center Copenhagen, Herlev, Denmark.
Signe Abitz WintherSteno Diabetes Center Copenhagen, Herlev, Denmark.
Simone TheiladeSteno Diabetes Center Copenhagen, Herlev, Denmark.
Peter RossingSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID 0000-0002-1531-4294
Marie Frimodt-MøllerSteno Diabetes Center Copenhagen, Herlev, Denmark.
Allan LinnebergCenter for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Funding

Novo Nordisk Fonden NNF19OC0058130
6 · The paper itself

Abstract

BACKGROUND AND

aimVitamin K deficiency is common in persons with kidney disease, which is a known complication of diabetes. We aimed to assess the association of vitamin K status as reflected by plasma dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP) with mortality, cardiovascular disease (CVD) and progression to end-stage kidney disease (ESKD) in persons with type 1 diabetes. MATERIALS AND

methodsWe analysed plasma dp-ucMGP in stored baseline samples from a cohort of 667 persons with type 1 diabetes (baseline visit: 2009-2011). Information on mortality and CVD was obtained through linkage to registers. Cox-proportional hazards models were applied to estimate hazard ratios (HRs) of mortality, CVD and ESKD per one doubling of dp-ucMGP.

resultsA total of 53 deaths were recorded during follow-up. Persons with higher dp-ucMGP (reflecting lower vitamin K status) had higher mortality in the unadjusted model (HR: 2.06 [95% confidence interval-CI: 1.22-3.45]), but not in the fully adjusted model (HR: 0.88 [95% CI: 0.44-1.73]). Particularly, adjustment for glomerular filtration rate and urinary albumin excretion rate attenuated the HR. A similar pattern was observed in unadjusted models for incidence of CVD (HR: 1.58 [95% CI: 1.03-2.42]) and risk of ESKD (HR: 7.62 [95% CI: 4.25-13.68]). In the fully adjusted models, the HRs became statistically insignificant.

conclusionIn persons with type 1 diabetes, lower vitamin K status was associated with higher mortality, CVD and progression to ESKD, however, not after adjustment for other risk factors. Interventional studies are needed to elucidate the role of vitamin K in persons with type 1 diabetes.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 1Diabetic NephropathiesKidney Failure, ChronicMatrix Gla ProteinVitamin KVitamin K DeficiencyAdultCalcium-Binding ProteinsCause of DeathCohort StudiesDisease ProgressionExtracellular Matrix ProteinsFemaleHumansMaleCalcium-Binding ProteinsExtracellular Matrix ProteinsMatrix Gla ProteinVitamin Kcardiovascular diseasecohort studydiabeticnephropathytype 1 diabetes

Identifiers

PMID39434445
PMCPMC11618244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.